This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: The Innovations of Harald Kandolf
Introduction
Harald Kandolf is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of genetics, particularly in the development of units for inhibiting the function of RNA. His work has implications for various applications in biotechnology and medicine.
Latest Patents
Kandolf holds a patent for "Genetics units for inhibiting the function of RNA." This innovation showcases his expertise in genetic engineering and its potential to influence therapeutic strategies.
Career Highlights
Throughout his career, Kandolf has worked with prominent companies, including Boehringer Ingelheim International GmbH. His experience in such reputable organizations has allowed him to refine his skills and contribute to groundbreaking research.
Collaborations
Kandolf has collaborated with esteemed colleagues such as Hartmut Beug and Max L. Birnstiel. These partnerships have enriched his work and expanded the impact of his inventions.
Conclusion
Harald Kandolf's contributions to genetics and his innovative patent reflect his dedication to advancing scientific knowledge. His work continues to inspire future developments in the field.